|Bid||69.03 x 800|
|Ask||69.14 x 800|
|Day's Range||67.11 - 70.05|
|52 Week Range||67.11 - 110.12|
|Beta (3Y Monthly)||-0.08|
|PE Ratio (TTM)||22.50|
|Earnings Date||Nov 6, 2018|
|Forward Dividend & Yield||2.20 (3.09%)|
|1y Target Est||90.33|
The Company recently filed its financial statements and corresponding MD&A and certifications for the fiscal years ended March 31, 2017 and 2018. It has also filed its interim financial statements, MD&A and certifications for the three months ended June 30, 2018. The Company’s current officers and directors are: Carl von Einsiedel – CEO and interim CFO and Director, and Garth Kirkham - Director. The Company intends to add additional directors so as to comply with TSX Venture Exchange policies. In that regard, the Company has scheduled an annual and special shareholders’ meeting for November 9, 2018. The Company recently filed notice that it changed its auditor from De Visser Gray LLP to Wolrige Mahon LLP. The Company noted that (i) De Visser had not expressed any reservation in its reports for, and (ii) no “reportable event” as defined in NI 51-102, had occurred with respect to the most recently completed fiscal year (2013) for which De Visser issued an audit report in respect of the Company, nor for the period therefrom to the date of the notice.
The market watcher's comments come just as recreational marijuana is legalized in Canada on Wednesday. Damodaran expects the industry's key players to remain in Canada, while business in the U.S. is "handicapped" by differing regulations between the state and federal levels.
To be honest, I’m not entirely thrilled about investing in marijuana stocks at the moment. Initial products such as Epidiolex and Sativex are used to treat epilepsy and spasticity caused by multiple sclerosis.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Basic Materials sector is rising.
Cowen analyst Viven Azer nearly tripled her price target on Tilray, the leading pot stock, to $172 from $62, maintaining and outperform rating.
The Scotts Miracle-Gro Foundation today announced its multi-year partnership with the National Head Start Association to combat some of the most pressing challenges facing today’s youngest generation, improving access to healthy food and increasing time spent outdoors connected to nature. The three-year partnership will work to bring the powerful, life-enhancing benefits of gardens to one million at-risk Head Start children and families across the country each year through the development of edible gardens and hands-on garden education. The Scotts Miracle-Gro Foundation and the National Head Start Association will make garden grants, garden kits, educational curriculum, and garden training available to all Head Start programs in the U.S. with the goal of creating more edible gardens and interactive learning experiences for young children and their families, ultimately teaching them how to grow their own healthy food––for life.
NEW YORK, NY / ACCESSWIRE / October 1, 2018 / Marijuana stocks Cronos Group and Scotts Miracle-Gro were both in the green on Friday despite no news from either company. Cronos Group Inc. shares were up 1.65% on Friday on nearly 11 million shares traded. There was no significant news from the marijuana company but in September 1st week, it and Ginkgo announced a deal to produce cannabinoids.
NEW YORK, Oct. 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AbbVie ...
The cannabis industry is taking off, but these two stocks offer significantly less risk than growers and product formulators. Which is the better buy?
In the latest move toward consolidation in the industry, High Times announced Wednesday it has acquired DOPE Media in a split of cash and stock transaction valued at $11.2 million. "The acquisition of Dope Media will be a key building block as we continue on our mission to create brand-safe inventory for brands of all sizes," High Times CEO Adam Levin told Benzinga.
Last week’s wild trading in cannabis stocks apparently hasn’t discouraged investors from jumping into new listings as pot producer Flowr Corp. nearly tripled in its trading debut Wednesday.
The Flowr Corporation (TSXV:FLWR) (“Flowr” or “Company”) announced that it expects its shares to be available for trading on the TSX Venture Exchange (“Exchange”) under the symbol FLWR at market open today, September 26, 2018. This follows the recent completion by Flowr of both an oversubscribed $C36 million capital raise and reverse takeover of a capital pool company previously listed on the Exchange. “This is an exciting day and important step toward our goal of becoming one of Canada’s top licensed producers,” said Vinay Tolia, Flowr’s CEO.
What you need to know about the past, present, and future of marijuana legalization nationwide.
Canada's cannabis market is big. But the U.S. is where the real money is, and these three marijuana stocks are the biggest in the U.S. market.
The Scotts Miracle-Gro Company (SMG), unlike other cannabis companies (HMMJ) like Canopy Growth (CGC) (WEED) and Tilray (TLRY), has large exposure to the lawn and gardening business in the US. The number of analysts recommending a “hold” remained unchanged at one, and three analysts continued to have a “sell” recommendation on the stock.
In this series, we’ll look at changes in ratings and price targets for some of the major cannabis stocks. August was very positive for the sector (HMMJ) with some companies delivering returns in excess of 100% YTD (year-to-date). The momentum has continued in September as well. Let’s discuss the performances of some of the cannabis stocks before we dive into analysts’ ratings and price target updates.
While cannabis stocks are rising, some warn that investors may want to steer clear. Yahoo Finance’s Alexis Christoforous sits down with Lane Mendelsohn, President of Vantage Point.